ETF Building Blocks ChannelDon’t Miss Out on Rampant Biotech Mergers with the SBIO ETFBy Tom LydonJanuary 13, 2021
FeaturedModerna Helps Biotech ETFs Mitigate Massive Losses as Stocks TumbleBy Ian YoungJanuary 4, 2021
FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
ETF Building Blocks ChannelHow Increased FDA Activity Can Benefit ETFs in Your PortfolioBy Tom LydonNovember 19, 2020
Equity ETF ChannelBiotech ETFs Poised for Gains after Moderna Vaccine NewsBy Ian YoungNovember 16, 2020
ETF Building Blocks ChannelMore than Just COVID: Hot ETFs for Medical BreakthroughsBy Tom LydonNovember 5, 2020
Equity ETF ChannelETF Strategies to Tap into Medical Breakthroughs, Healthcare InnovationsBy Max ChenOctober 30, 2020
Tactical Allocation ChannelCan’t Get Enough Biotech Exposure in Your Portfolio?By Ben HernandezOctober 29, 2020
ETF Building Blocks ChannelPost-Election Considerations for a Nifty Biotech ETFBy Tom LydonOctober 7, 2020
Leveraged & Inverse ChannelShort Sellers Back Off From Biotech ETFsBy Ben HernandezSeptember 28, 2020
